High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions

Eric A. Kumar, Casey D. Charvet, G. L. Lokesh, Amarnath Natarajan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The casitas B-lineage lymphoma (Cbl) proteins play an important role in regulating signal transduction pathways by functioning as E3 ubiquitin ligases. The Cbl proteins contain a conserved tyrosine kinase binding (TKB) domain that binds more than a dozen proteins, including protein tyrosine kinases (PTKs), in a phosphorylation-dependent manner. The cell surface expression levels of the PTKs are regulated by Cbl-mediated ubiquitination, internalization, and degradation. Dysfunction in this signaling cascade has resulted in prolonged activation of the PTKs and, therefore, has been implicated in inflammatory diseases and various cancers. Due to this negative regulatory function, Cbl has been largely ignored as a therapeutic target. However, recent studies, such as the identification of (i) gain of function c-Cbl mutations in subsets of myeloid cancer and (ii) c-Cbl as a prostate basal cell marker that correlates with poor clinical outcome, suggest otherwise. Here we report the development of a competitive high-throughput fluorescence polarization assay in a 384-well format to identify inhibitors of Cbl(TKB). The high-throughput screen readiness of the assay was demonstrated by screening the Prestwick Chemical Library.

Original languageEnglish (US)
Pages (from-to)254-260
Number of pages7
JournalAnalytical Biochemistry
Volume411
Issue number2
DOIs
StatePublished - Apr 15 2011

Fingerprint

Fluorescence Polarization
Protein-Tyrosine Kinases
Assays
Lymphoma
Carrier Proteins
Fluorescence
Oncogene Protein v-cbl
Throughput
Polarization
Small Molecule Libraries
Signal transduction
Phosphorylation
Ubiquitin-Protein Ligases
Ubiquitination
Set theory
Prostate
Signal Transduction
Neoplasms
Screening
Chemical activation

Keywords

  • Cbl-PTK inhibitors
  • Fluorescence polarization assay
  • High-throughput screening

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology
  • Cell Biology

Cite this

High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions. / Kumar, Eric A.; Charvet, Casey D.; Lokesh, G. L.; Natarajan, Amarnath.

In: Analytical Biochemistry, Vol. 411, No. 2, 15.04.2011, p. 254-260.

Research output: Contribution to journalArticle

@article{6018f3fab1564785afa971f3c1949d8c,
title = "High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions",
abstract = "The casitas B-lineage lymphoma (Cbl) proteins play an important role in regulating signal transduction pathways by functioning as E3 ubiquitin ligases. The Cbl proteins contain a conserved tyrosine kinase binding (TKB) domain that binds more than a dozen proteins, including protein tyrosine kinases (PTKs), in a phosphorylation-dependent manner. The cell surface expression levels of the PTKs are regulated by Cbl-mediated ubiquitination, internalization, and degradation. Dysfunction in this signaling cascade has resulted in prolonged activation of the PTKs and, therefore, has been implicated in inflammatory diseases and various cancers. Due to this negative regulatory function, Cbl has been largely ignored as a therapeutic target. However, recent studies, such as the identification of (i) gain of function c-Cbl mutations in subsets of myeloid cancer and (ii) c-Cbl as a prostate basal cell marker that correlates with poor clinical outcome, suggest otherwise. Here we report the development of a competitive high-throughput fluorescence polarization assay in a 384-well format to identify inhibitors of Cbl(TKB). The high-throughput screen readiness of the assay was demonstrated by screening the Prestwick Chemical Library.",
keywords = "Cbl-PTK inhibitors, Fluorescence polarization assay, High-throughput screening",
author = "Kumar, {Eric A.} and Charvet, {Casey D.} and Lokesh, {G. L.} and Amarnath Natarajan",
year = "2011",
month = "4",
day = "15",
doi = "10.1016/j.ab.2010.11.038",
language = "English (US)",
volume = "411",
pages = "254--260",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - High-throughput fluorescence polarization assay to identify inhibitors of Cbl(TKB)-protein tyrosine kinase interactions

AU - Kumar, Eric A.

AU - Charvet, Casey D.

AU - Lokesh, G. L.

AU - Natarajan, Amarnath

PY - 2011/4/15

Y1 - 2011/4/15

N2 - The casitas B-lineage lymphoma (Cbl) proteins play an important role in regulating signal transduction pathways by functioning as E3 ubiquitin ligases. The Cbl proteins contain a conserved tyrosine kinase binding (TKB) domain that binds more than a dozen proteins, including protein tyrosine kinases (PTKs), in a phosphorylation-dependent manner. The cell surface expression levels of the PTKs are regulated by Cbl-mediated ubiquitination, internalization, and degradation. Dysfunction in this signaling cascade has resulted in prolonged activation of the PTKs and, therefore, has been implicated in inflammatory diseases and various cancers. Due to this negative regulatory function, Cbl has been largely ignored as a therapeutic target. However, recent studies, such as the identification of (i) gain of function c-Cbl mutations in subsets of myeloid cancer and (ii) c-Cbl as a prostate basal cell marker that correlates with poor clinical outcome, suggest otherwise. Here we report the development of a competitive high-throughput fluorescence polarization assay in a 384-well format to identify inhibitors of Cbl(TKB). The high-throughput screen readiness of the assay was demonstrated by screening the Prestwick Chemical Library.

AB - The casitas B-lineage lymphoma (Cbl) proteins play an important role in regulating signal transduction pathways by functioning as E3 ubiquitin ligases. The Cbl proteins contain a conserved tyrosine kinase binding (TKB) domain that binds more than a dozen proteins, including protein tyrosine kinases (PTKs), in a phosphorylation-dependent manner. The cell surface expression levels of the PTKs are regulated by Cbl-mediated ubiquitination, internalization, and degradation. Dysfunction in this signaling cascade has resulted in prolonged activation of the PTKs and, therefore, has been implicated in inflammatory diseases and various cancers. Due to this negative regulatory function, Cbl has been largely ignored as a therapeutic target. However, recent studies, such as the identification of (i) gain of function c-Cbl mutations in subsets of myeloid cancer and (ii) c-Cbl as a prostate basal cell marker that correlates with poor clinical outcome, suggest otherwise. Here we report the development of a competitive high-throughput fluorescence polarization assay in a 384-well format to identify inhibitors of Cbl(TKB). The high-throughput screen readiness of the assay was demonstrated by screening the Prestwick Chemical Library.

KW - Cbl-PTK inhibitors

KW - Fluorescence polarization assay

KW - High-throughput screening

UR - http://www.scopus.com/inward/record.url?scp=79952453470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952453470&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2010.11.038

DO - 10.1016/j.ab.2010.11.038

M3 - Article

VL - 411

SP - 254

EP - 260

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 2

ER -